PREVYMIS TABLETS (letermovir tablets) Patient Assistance Program
Don’t let the high cost of brand CMV prophylaxis therapy disrupt your transplant care. We help eligible patients access Prevymis (letermovir tablets) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Prevymis (letermovir) is FDA-approved for prophylaxis of CMV infection and disease in adult CMV-seropositive recipients of allogeneic hematopoietic stem cell transplant (HSCT), and for kidney transplant patients receiving prophylaxis after donor+/recipient- (D+/R-) high-risk transplant. CMV DNA terminase inhibitor.
- Without assistance, Prevymis costs commonly run approximately $5,000–$8,000 per 30-day supply.
- Through AffordMyPrescriptions, qualifying patients can access Prevymis for a flat $69.95 per month.
- There is no generic Prevymis currently. Alternative CMV prophylaxis: valganciclovir (Valcyte — generic, much cheaper but causes myelosuppression and resistance), preemptive monitoring strategy (CMV PCR monitoring + treatment when detected).
What Is Prevymis Tablets Prescription Assistance Program?
Prevymis PAP for HSCT/kidney transplant patients.
Eligibility, transplant coordination.
AffordMyPrescriptions eliminates that burden. $69.95/month advocacy.
Pharmacy Price Comparison
- Prevymis pellets $5,000–$8,000/month. PAP critical:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$7,500 | Save substantially |
| CVS Pharmacy | ~$8,000 | Save substantially |
| Walmart | ~$5,300 | Save substantially |
| Costco | ~$5,100 | Save substantially |
Specialty Pharmacy | ~$6,000 | Save substantially |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Prevymis Tablets Prescription Program?
PAP at no cost. Generic valganciclovir alternative (less effective for prophylaxis, more side effects, but dramatically cheaper).
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Prevymis Tablets:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $5,000–$8,000/month per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Prevymis Tablets assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Prevymis Tablets Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Prevymis Tablets:
Prevymis is first-in-class CMV DNA terminase inhibitor for CMV prophylaxis in transplant. Major advance over valganciclovir for HSCT prophylaxis — no myelosuppression, no nephrotoxicity, doesn’t cause antiviral resistance like ganciclovir.
How Prevymis Tablets Works:
CMV reactivation after transplant causes significant morbidity. Historically managed with preemptive valganciclovir (toxic, myelosuppressive, resistance-prone) or universal prophylaxis with valganciclovir.
Letermovir targets CMV-specific viral terminase complex — essential for viral DNA packaging. Highly specific antiviral with minimal host toxicity. No effect on cellular DNA synthesis, no myelosuppression. Doesn’t share resistance pathways with ganciclovir.
Form and use:
Prevymis 480 mg once daily by mouth from transplant day 0 (or up to day 28) through day 100 post-HSCT. Or 480 mg daily for 200 days post kidney transplant (D+/R-).
Generic availability:
No generic Prevymis. Valganciclovir (Valcyte) generic alternative — older, more toxic (myelosuppression dose-limiting in HSCT), resistance issues, but very cheap. Preemptive monitoring strategy: monitor CMV PCR, treat when detected (less drug exposure but requires close monitoring).
Warnings:
Generally well-tolerated. Drug interactions (CYP3A inhibitor — affects calcineurin inhibitor levels — tacrolimus, cyclosporine; statins; many others). Hepatic adverse events. Hypersensitivity. Use with cyclosporine requires letermovir dose reduction to 240 mg.
FAQ (Frequently Asked Questions)
Cost?
$5,000–$8,000/month. PAP critical. Generic valganciclovir alternative ~$300/month.
Prevymis vs valganciclovir?
Prevymis specific anti-CMV — no myelosuppression, no nephrotoxicity, no antiviral resistance. Valganciclovir broader antiviral but myelosuppressive (often dose-limiting in HSCT). Prevymis preferred for HSCT prophylaxis.
Drug interactions?
Significant CYP3A inhibitor — must adjust calcineurin inhibitor doses. Coordinate with transplant pharmacy.
Denied?
Generic valganciclovir alternative. Preemptive monitoring strategy. Hospital charity, transplant programs may help.
Take Control of Your Medication Costs
If facing Prevymis cost, PAP and transplant program assistance help. Check eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.